Steve Swallow

7.9k total citations · 1 hit paper
10 papers, 6.9k citations indexed

About

Steve Swallow is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steve Swallow has authored 10 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steve Swallow's work include Pharmacogenetics and Drug Metabolism (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper) and Synthesis of heterocyclic compounds (1 paper). Steve Swallow is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper) and Synthesis of heterocyclic compounds (1 paper). Steve Swallow collaborates with scholars based in United Kingdom, Sweden and United States. Steve Swallow's co-authors include Véronique Gouverneur, Sophie Purser, Peter R. Moore, Yan Li, Lars Weidolf, Brian Middleton, J. Gerry Kenna, Richard Weaver, Hugues Dolgos and Alison J. Foster and has published in prestigious journals such as Chemical Society Reviews, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Steve Swallow

10 papers receiving 6.8k citations

Hit Papers

Fluorine in medicinal chemistry 2007 2026 2013 2019 2007 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Swallow United Kingdom 7 5.2k 5.2k 1.7k 843 211 10 6.9k
Carlos del Pozo Spain 31 3.9k 0.7× 5.8k 1.1× 1.5k 0.9× 1.2k 1.4× 244 1.2× 111 7.0k
Peter R. Moore United Kingdom 17 5.5k 1.1× 5.8k 1.1× 1.9k 1.1× 953 1.1× 230 1.1× 39 7.5k
María Sánchez‐Roselló Spain 29 3.9k 0.7× 6.0k 1.2× 1.4k 0.8× 1.1k 1.4× 238 1.1× 68 7.1k
Sophie Purser United Kingdom 6 5.4k 1.0× 5.3k 1.0× 1.8k 1.0× 787 0.9× 202 1.0× 9 6.8k
Danièle Bonnet‐Delpon France 38 2.8k 0.5× 4.6k 0.9× 874 0.5× 1.1k 1.3× 205 1.0× 149 5.6k
Kunisuke Izawa Japan 27 3.1k 0.6× 4.0k 0.8× 1.4k 0.8× 1.3k 1.6× 305 1.4× 110 5.4k
Etsuko Tokunaga Japan 45 4.5k 0.9× 5.1k 1.0× 2.0k 1.2× 886 1.1× 267 1.3× 158 6.9k
Alexander E. Sorochinsky Ukraine 34 5.0k 1.0× 5.7k 1.1× 1.7k 1.0× 2.0k 2.4× 695 3.3× 76 7.6k
Jean‐Pierre Bégué France 34 2.6k 0.5× 3.8k 0.7× 746 0.4× 893 1.1× 161 0.8× 125 4.7k
Günter Haufe Germany 35 2.6k 0.5× 3.8k 0.7× 948 0.6× 1.6k 1.8× 487 2.3× 291 5.5k

Countries citing papers authored by Steve Swallow

Since Specialization
Citations

This map shows the geographic impact of Steve Swallow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Swallow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Swallow more than expected).

Fields of papers citing papers by Steve Swallow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Swallow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Swallow. The network helps show where Steve Swallow may publish in the future.

Co-authorship network of co-authors of Steve Swallow

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Swallow. A scholar is included among the top collaborators of Steve Swallow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Swallow. Steve Swallow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kingston, Lee, Chungang Gu, Jian Guo, Steve Swallow, & Charles S. Elmore. (2020). The impact of radiochemistry in drug projects: The use of C‐14 label in the AZD8529, AZD7325, and AZD6280 projects. Journal of Labelled Compounds and Radiopharmaceuticals. 64(2). 65–72. 4 indexed citations
2.
Doyle, Kevin, Hans Lönn, Helena Käck, et al.. (2016). Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). Journal of Medicinal Chemistry. 59(20). 9457–9472. 62 indexed citations
3.
Bragg, Ryan A., et al.. (2015). Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation. Chemical Research in Toxicology. 28(10). 1991–1999. 26 indexed citations
4.
Männikkö, Roope, Hayley Pye, Steve Swallow, et al.. (2015). Pharmacological and electrophysiological characterization of AZSMO‐23, an activator of the hERG K+ channel. British Journal of Pharmacology. 172(12). 3112–3125. 19 indexed citations
5.
Graham, M. A., Paul A. Bethel, Jonathan Burgess, et al.. (2013). Novel and Versatile Synthesis of Disubstituted 1,2-Dihydro-1,2,4-triazol-3-ones. Organic Letters. 15(23). 6078–6081. 5 indexed citations
6.
Thompson, Richard A., Emre M. Isin, Yan Li, et al.. (2012). In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs. Chemical Research in Toxicology. 25(8). 1616–1632. 153 indexed citations
7.
Brown, Dearg S., John G. Cumming, Paul A. Bethel, et al.. (2012). The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 22(12). 3879–3883. 9 indexed citations
8.
Luker, Tim, Lilian Alcaraz, Kamaldeep K. Chohan, et al.. (2011). Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. Bioorganic & Medicinal Chemistry Letters. 21(19). 5673–5679. 49 indexed citations
9.
Purser, Sophie, Peter R. Moore, Steve Swallow, & Véronique Gouverneur. (2007). Fluorine in medicinal chemistry. Chemical Society Reviews. 37(2). 320–330. 6564 indexed citations breakdown →
10.
Harwood, Laurence M., et al.. (1999). Singlet Oxygen Cycloaddition to Dienes: a Biomimetic Approach to Marine Endoperoxides?. Synlett. 1999(9). 1359–1362. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026